| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8853 |
| Human Intestinal Absorption | HIA+ | 0.5753 |
| Caco-2 Permeability | Caco2+ | 0.5377 |
| P-glycoprotein Substrate | Non-substrate | 0.8493 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9875 |
| Non-inhibitor | 0.9724 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9370 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4840 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8271 |
| CYP450 2D6 Substrate | Non-substrate | 0.8894 |
| CYP450 3A4 Substrate | Non-substrate | 0.8105 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8859 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8932 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9492 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9310 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9618 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9457 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9397 |
| Non-inhibitor | 0.9679 |
| AMES Toxicity | Non AMES toxic | 0.7670 |
| Carcinogens | Carcinogens | 0.6211 |
| Fish Toxicity | Low FHMT | 0.9395 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8085 |
| Honey Bee Toxicity | High HBT | 0.7000 |
| Biodegradation | Ready biodegradable | 0.8605 |
| Acute Oral Toxicity | III | 0.4528 |
| Carcinogenicity (Three-class) | Non-required | 0.6498 |